TEVA · Teva elected Dr

Teva elected Dr. David J. Brailer to its Board of Directors, effective November 3, 2026, until the 2027 annual meeting. Dr. Brailer is an independent director with a background in health-tech and managed care, and will serve on the Human Resources and Compensation and Compliance Committees. This is a routine board appointment with no material financial impact.

• Dr. David J. Brailer elected to Teva's Board effective November 3, 2026
• Dr. Brailer qualifies as an independent director under NYSE listing rules
• He will serve on the Human Resources and Compensation and Compliance Committees
• Compensation is the same as other non-executive directors, as described in the March 31, 2026 proxy statement